BIONEERCORPORATION Logo

BIONEERCORPORATION

Provides molecular biology tools & diagnostic kits for research and clinical applications.

064550 | KO

Overview

Corporate Details

ISIN(s):
KR7064550007
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노2로 71 (주)바이오니아 글로벌센터, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1992, Bioneer Corporation is a biotechnology company specializing in molecular biology products and technologies. The company develops, manufactures, and supplies a comprehensive portfolio for the life sciences and molecular diagnostics (MDx) markets. Its core offerings include proprietary MDx systems and diagnostic kits for various infectious diseases, such as SARS-CoV-2, HIV, HBV, and HCV. Bioneer also provides a wide array of molecular biology reagents, gene synthesis services, PCR systems, and recombinant proteins. A key area of innovation is in laboratory instrumentation, including its patented AccuLoader™ precision device for automated sample handling. The company serves research, clinical, and industrial customers, providing a platform for disease prevention, diagnosis, and treatment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-07-31 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-06-18 00:00
Legal Proceedings Report
횡령ㆍ배임혐의진행사항
Korean 6.4 KB
2025-06-12 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-06-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-30 00:00
Regulatory Filings
소속부변경
Korean 3.6 KB
2025-04-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.0 KB
2025-03-31 00:00
AGM Information
정기주주총회결과
Korean 21.3 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 26.2 KB
2025-03-21 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 644.0 KB
2025-03-20 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 123.8 KB
2025-03-04 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all BIONEERCORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIONEERCORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIONEERCORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

UNION KOREA PHARM CO.,Ltd Logo
Develops and manufactures prescription drugs like antibiotics and analgesics for global markets.
South Korea
080720
uniQure N.V. Logo
Developing AAV-based gene therapies for rare liver and central nervous system disorders.
United States of America
QURE
UNITED THERAPEUTICS Corp Logo
Develops therapies for chronic diseases and manufactures organs for transplantation.
United States of America
UTHR
Universe Pharmaceuticals INC Logo
Manufactures, markets, and distributes TCM derivative products and biomedical drugs.
United States of America
UPC
Univo Pharmaceuticals Ltd. Logo
Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.
Israel
UNVO-M
Upstream Bio, Inc. Logo
Developing a monoclonal antibody for severe inflammatory and respiratory diseases.
United States of America
UPB
UroGen Pharma Ltd. Logo
Develops non-surgical therapies for urological cancers using proprietary hydrogel technology.
United States of America
URGN
Valneva SE Logo
Develops and commercializes vaccines for infectious diseases like chikungunya, Lyme, and Zika.
France
VLA
Vanda Pharmaceuticals Inc. Logo
Develops and commercializes innovative therapies for central nervous system disorders.
United States of America
VNDA
Vaxcell-Bio Therapeutics Logo
Develops CAR-T and CAR-NK immunotherapies for solid tumors and canine lymphoma.
South Korea
323990

Talk to a Data Expert

Have a question? We'll get back to you promptly.